Browsed by
Category: Press Releases

United Therapeutics Announces FDA Approval of Tyvaso DPI™

United Therapeutics Announces FDA Approval of Tyvaso DPI™

First approval of a dry powder inhaler for treatment of PAH and PH-ILD

DPI device represents a convenient option for administration of treprostinil therapy

Commercial launch activities underway; patient availability expected in June 2022

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–May 24, 2022–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. Tyvaso DPI represents a new formulation and inhalation device for inhaled treprostinil and is the only dry powder inhaler approved by the FDA for use in PAH and PH-ILD. ...  Read more

TEDCO to Receive up to $50 Million from State Small Business Credit Initiative

TEDCO to Receive up to $50 Million from State Small Business Credit Initiative

COLUMBIA, Md. (May 25, 2022)TEDCO, Maryland’s economic engine for technology companies, announced today it will receive up to $50 million from Governor Hogan’s small business relief plan that was approved for funding from the United States Treasury Department’s State Small Business Credit Initiative (SSBCI). TEDCO will allocate the funds into four existing programs targeting technology-based Maryland businesses and entrepreneurs. ...  Read more

Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology

Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology

Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been selected for this award from among so many highly innovative competitors. ...  Read more

MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces  that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pioneer in adult stem cells. ...  Read more